Novavax has received Emergency Use Authorization from the U.S. #FDA for its updated COVID-19 vaccine in individuals aged 12 and older. Pre-filled syringes are expected to be available in thousands of locations across the U.S. in the coming days.
Read the press release:… pic.twitter.com/mfv4uhU3gW
— Novavax (@Novavax) August 30, 2024
Today, we granted emergency use authorization for an updated Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. https://t.co/xzOuIpmSPe pic.twitter.com/0uyHwyaD5Z
— U.S. FDA (@US_FDA) August 30, 2024
Here we go again.
The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax’s COVID shot.
The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus.
Shares of the company were up 2.2% in extended trading after closing 8.6% higher.
“Today’s authorization provides an additional COVID-19 vaccine option,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
…
Novavax’s traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA – Moderna’s Spikevax and Comirnaty, which is jointly developed by Pfizer and BioNTech.
Who is taking these vaccines at this point?
Apparently, it’s the people who still have “stand with the Ukraine” flags in their yards. Maybe those people are also still chanting “black lives matter.”
$3,000 and a Toy: Novavax Dangles Incentives to Fill Clinical Trials on Covid Shots for Babies, Kids. Do they throw in a free coffin and burial plan? https://t.co/EBlE3YlJ0z
— Alex Jones (@RealAlexJones) August 30, 2024